Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Tapeworm 'a significant pathogen in young horses'
"The benefit of testing for tapeworm is that anti-tapeworm dosing frequency and management practices can be altered in response to results" - Jess Spanton, lead veterinary surgeon.
Owners urged to keep a close eye on tapeworm infections in their animals.

Tapeworm should be considered a significant pathogen in young horses, according to findings presented at the recent equine colic symposium (4-7 September).

Researchers investigating individual colic cases in four yearlings found that cases occurred over several years at a well-managed thoroughbred stud farm. Two of the yearlings required euthanasia, while two made a full recovery. 

A post-mortem of three yearlings revealed large live tapeworm infections, and three of the cases suffered ileocaecal intussusception - where a section of the intestine slides inside an adjacent section. This finding was despite the yearlings being given praziquantel at six and 12 months of age. 

Researchers were most concerned two of the live tapeworm infections were found days after the yearlings had received the praziquantel, thereby raising suspicions of drug resistance.

Lead veterinary surgeon Jess Spanton, a specialist in internal medicine at House and Jackson Equine Hospital, explained: “While this case study hasn’t generated firm conclusions of praziquantel resistance, the large live tapeworm infections discovered days after treatment are very concerning, suggesting that a level of resistance to anti-tapeworm treatments is a strong possibility.”

Ms Spanton suggests that tapeworm infections should be closely monitored, particularly in young horses, to prevent suffering from serious diseases.

“The benefit of testing for tapeworm is that anti-tapeworm dosing frequency and management practices can be altered in response to results, and in some cases may identify whether there is a potential for resistance,” she said. 

Become a member or log in to add this story to your CPD history

Free CPD announced for BVNA members

News Story 1
 Zoetis is to present a CPD event for free to members of the British Veterinary Nursing Association (BVNA).

Led by veterinary consultant Ruth Moxon, the one-hour online session is designed to help veterinary nurses discuss parasiticide options with clients. It will advise on structuring recommendations, factors for product choice and moving away from 'selling'.

'How do you recommend parasite treatments to your clients?' will be presented on Tuesday, 20 May at 7.30pm. It is free for BVNA members, with £15.00 tickets for non-members.

Veterinary nurses can email cpd@bvna.co.uk to book their place. 

Click here for more...
News Shorts
DAERA to reduce BVD 'grace period'

DAERA has reminded herd keepers of an upcoming reduction to the 'grace period' to avoid BVD herd restrictions.

From 1 May 2025, herd keepers will have seven days to cull any BVD positive or inconclusive animals to avoid restrictions being applied to their herd.

It follows legislation introduced on 1 February, as DAERA introduces herd movement restrictions through a phased approach. Herd keepers originally had 28 days to cull BVD positive or inconclusive animals.

DAERA says that, providing herd keepers use the seven-day grace period, no herds should be restricted within the first year of these measures.

Additional measures, which will target herds with animals over 30 days old that haven't been tested for BVD, will be introduced from 1 June 2025.

More information is available on the DAERA website.